NCT01494246

Brief Summary

Objectives. To evaluate the effectiveness and cost effectiveness of clinical practice guide based intervention with two face-to-face visits and e-mail tracking compared to brief advice to obtain continued smoking abstinence at 6 and 12 months after intervention. Methodology. simple randomized controlled multicentric trial. All smokers (N=1064) aged 18 or older that attend by any reason to the primary care center and that have an e-mail account and they checked it at least once a week will be invited to participate. The enrolled participants will be randomly divided into control (N=532) and intervention group (N=532). An intensive intervention, based on the recommendations of the clinical practice guides, that will include six contacts (2 face-to-face and 4 by e-mail) will be applied to the intervention group. Control group will receive brief advice. The main dependent variable will be continued abstinence of tobacco consumption at six and twelve months after the beginning of the intervention which will be validated by and a carbon monoxide breathe analysis measured by a cooximeter in standard conditions. Secondary variables will include: stage change on the quitting smoking process and evaluation of the effectiveness on the reduction of the number of smoked cigarettes at six and twelve months after intervention. A descriptive analysis of all variables will be done. A multivariate analysis will be undertaken to assess differences among intervention and control group; logistic regression for dichotomic variables and lineal regression for continuous variables.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,064

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Dec 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2011

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 16, 2011

Completed
12 months until next milestone

Study Start

First participant enrolled

December 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

June 19, 2014

Status Verified

June 1, 2014

Enrollment Period

9 months

First QC Date

November 30, 2011

Last Update Submit

June 18, 2014

Conditions

Keywords

Adultcomputer-assisted instructionelectronic mailprogram evaluationsmoking cessation/methodscontinued abstinence

Outcome Measures

Primary Outcomes (1)

  • Change in smoking status and maintenance in smoking cessation

    The term used to name long term abstinence over 6 months is continuous abstinence.

    the outcome measure is studied at 6 and 12 months

Secondary Outcomes (7)

  • point prevalence abstinence

    the outcome measure is studied at 3, 6 and 12 months

  • self-reported tobacco consumption

    the outcome measure is studied at 3, 6 and 12 months

  • self-reported smoking reduction

    the outcome measure will be studied at 3, 6 and 12 months

  • stage of change in Prochaska cycle

    the outcome measure will be studied at 3,6 and 12 months

  • used time by professionals to achieve patients stop smoking

    the outcome measure will be studied at 3, 6 and 12 months

  • +2 more secondary outcomes

Study Arms (2)

electronic mail

EXPERIMENTAL
Other: electronic mail

brief advise

NO INTERVENTION

Interventions

Some e-mail will be sent to participants who will be in the intervention group in order to intensify the brief advise received for stop smoking.

Also known as: e-mail, electronic mail, computer intervention,
electronic mail

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Smokers over 18 years old with an e-mail account who use frequently. (Smoker is an individual who smokes any amount of tobacco, whatever this amount it is.
  • E-mail regular user is the one who uses it as a way of communication at least once per week)

You may not qualify if:

  • Not regular e-mail users,
  • patients who have diseases that advise not to stop smoking:
  • Terminal diseases
  • Serious psychiatric disorders
  • Active addiction to other psychoactive drugs
  • Patients in smoking cessation process
  • whatever the cause that does not allow to understand goals and methodology of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordi Gol i Gurina Foundation. Research Unit of Barcelona. Lifestyles Research Group.

Barcelona, Barcelona, 08007, Spain

Location

Related Publications (1)

  • Diaz-Gete L, Puigdomenech E, Briones EM, Fabregas-Escurriola M, Fernandez S, Del Val JL, Ballve JL, Casajuana M, Sanchez-Fondevila J, Clemente L, Castano C, Martin-Cantera C; Grupo Estudio TABATIC. Effectiveness of an intensive E-mail based intervention in smoking cessation (TABATIC study): study protocol for a randomized controlled trial. BMC Public Health. 2013 Apr 18;13:364. doi: 10.1186/1471-2458-13-364.

    PMID: 23597262BACKGROUND

MeSH Terms

Conditions

Tobacco Use DisorderSmoking Cessation

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersHealth BehaviorBehavior

Study Officials

  • José L Ballvé Moreno, MD

    Institut Català de la Salut

    STUDY CHAIR
  • Marc Casajuana, Economist

    Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    STUDY CHAIR
  • Lourdes Clemente, MD

    Servicio Aragones De Salud

    STUDY CHAIR
  • Laura Díaz Gete, MD

    Institut Català de la Salut

    PRINCIPAL INVESTIGATOR
  • Elena M Briones Carrió, Statistician

    Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    STUDY CHAIR
  • Mireia Fàbregas Escurriola, MD

    Institut Català de la Salut

    STUDY CHAIR
  • Elisa Puigdomènech Puig, Byologist

    Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    STUDY CHAIR
  • José L del Val, MD

    Institut Català de la Salut

    STUDY CHAIR
  • Soraya Fernández Maestre, nurse

    Institut Català de la Salut

    STUDY CHAIR
  • Carlos Martín Cantera, MD, Ph D

    Institut Català de la Salut. Research Unit of Barcelona, IDIAP Jordi Gol. Department of Medicine, University Autonomus of Barcelona

    STUDY CHAIR
  • Ricardo Almon, MD, PhD

    Family Medicine Research centre School of Health and medical Sciences. Örebro University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2011

First Posted

December 16, 2011

Study Start

December 1, 2012

Primary Completion

September 1, 2013

Study Completion

December 1, 2014

Last Updated

June 19, 2014

Record last verified: 2014-06

Locations